Industries > Pharma > Drug Discovery Outsourcing Market Report 2020-2030
Drug Discovery Outsourcing Market Report 2020-2030
Forecasts by Service Type (Chemistry Services, Biology Services, Lead Identification & Screening Services, Lead Optimisation Services), Molecule Type (Large Molecule Drugs, Small Molecule Drugs), Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) PLUS COVID-19 Recovery Scenarios and Profiles of Leading Drug Discovery Outsourcing Companies
Discovery Outsourcing Market–our new study reveals trends, R&D progress, and predicted revenues
Where is the drug discovery outsourcing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 490-page report provides 327 tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Discover sales predictions for the world market and submarkets
Drug Discovery Outsourcing Market: By Service Type
• Chemistry Services
• Biology Services
• Lead Identification & Screening Services
• Lead Optimisation Services
Drug Discovery Outsourcing Market: By Molecule Type
• Large Molecule Drugs
• Small Molecule Drugs
Drug Discovery Outsourcing Market: By Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– United Kingdom
– Italy
– Spain
– Russia
– Rest of Europe
• Asia Pacific
– China
– Japan
– India
– Australia
– South Korea
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Rest of Latin America
• Middle East and Africa
– GCC
– South Africa
– Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the drug discovery outsourcing market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Drug Discovery Outsourcing Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Drug Discovery Outsourcing Market report helps you
In summary, our 490-page report provides you with the following knowledge:
• Revenue forecasts to 2030 for Drug Discovery Outsourcing Market, with forecasts for Service Type, Molecule Type, and Therapeutic Area, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the drug discovery outsourcing market in North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Drug Discovery Outsourcing Market. Some of the company’s profiled in this report include Evotec, GVK Bio, Charles River Laboratories, LabCorp, Domainex Ltd, Genscript Biotech Corporation, Jubilant Biosys Ltd – Gilead Sciences, Viva Biotech, WuXi AppTec, Dalton Pharma, Eurofins, and Syngene, Selvita.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Drug Discovery Outsourcing Market Analysis : Forecasts report between 2020 to 2030. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Drug Discovery Outsourcing Market
1.1. Global Drug Discovery Outsourcing Market Segmentation
1.2 Drug Discovery Outsourcing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.1.1 Impact of COVID 19 on Global Pharma Supply Chain
1.7.1.2 Worldwide air transportation availability and costs
1.7.1.3 Return of pharmaceutical manufacturing back to the US
1.7.1.4 Possible supply disruptions of drugs identified as potential treatments against COVID
1.7.1.5 Prescription refills
1.7.1.6 Impact of pharmaceutical companies in clinical need
1.7.1.7 Battle for cure
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Market Size Estimation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Drivers
3.1.1 Reduced pharmaceutical and biotech R&D budgets
3.1.2 Emerging Markets are a Popular Destination for CROs
3.1.3 Improving conditions in the industry will drive healthy growth
3.2 Restraints
3.2.1 Limited IP Protection
3.2.2 IP License Agreement Lengthy and Complex
3.3 Opportunities
3.3.1 Strategic Partnerships to Acquisitions
3.3.2 Recent Drug Development Outsourcing Agreements
3.3.3 Investment in Artificial Intelligence Booms in the field of Drug Discovery
3.4 Challenges
3.4.1 Challenges Face by the Drug Discovery Outsourcing Companies
3.5 Porter’s Five Forces Analysis
3.5.1 Threat of New Entrants: Medium
3.5.2 Power of Suppliers: Medium
3.5.3 Threat of Substitutes: Medium
3.5.4 Power of Buyers: High
3.5.5 Rivalry Among Competitors: High
3.6 SWOT Analysis
3.6.1 Strengths
3.6.1.1 Cost Reduction: A Central Driver for Outsourcing
3.6.1.2 Accelerating the Discovery of Drug Candidates
3.6.1.3 Growth of Virtual Pharmaceutical Companies
3.6.1.4 Reduction in R&D capacity Within Big Pharma
3.6.2 Weaknesses
3.6.2.1 Slowing Trajectory of Growth for R&D Spending
3.6.2.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
3.6.3 Opportunities
3.6.3.1 The Available Scope for the Expansion of CROs
3.6.3.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
3.6.3.3 Increasing Development of Biologics and Biosimilars
3.6.4 Threats
3.6.4.1 A Competitive Market is Increasing Consolidation
3.6.4.2 Threat of Private Public Alliances
3.6.4.3 Intellectual Property Leaks
3.6.4.4 Challenges of Technology Transfer
4 Global Drug Discovery Outsourcing Market Size Forecast 2020-2030 by Service Type
4.1 Global Drug Discovery Outsourcing Market for Chemistry Services Segment: Revenue Forecast 2020-2030 - Largest Segment of the Market
4.1.1 Global Drug Discovery Outsourcing Market for Chemistry Services Segment: Recovery Forecasts (V, U, W, L)
4.2 Global Drug Discovery Outsourcing Market for Biology Services Segment: Revenue Forecast 2020-2030 - Biological Insights is Central to the Drug Discovery Process
4.2.1 Global Drug Discovery Outsourcing Market for Biology Services Segment: Recovery Forecasts (V, U, W, L)
4.3 Global Drug Discovery Outsourcing Market for Lead Optimization Segment: Revenue Forecast 2020-2030 - Fastest Growing Market
4.3.1 Global Drug Discovery Outsourcing Market for Lead Optimization Segment: Recovery Forecasts (V, U, W, L)
4.4 Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment: Revenue Forecast 2020-2030 - Smallest Segment in the Market
4.4.1 Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment: Recovery Forecasts (V, U, W, L)
5 Global Drug Discovery Outsourcing Market Size Forecast 2020-2030 by Molecule Types
5.1 Global Drug Discovery Outsourcing Market by Molecule Type Forecast 2020-2030
5.2 Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment: Revenue Forecast 2020-2030
5.2.1 Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment: Recovery Forecasts (V, U, W, L)
5.2.2 Large Molecule Drugs Segment: Market is Growing More Rapidly in all Regions
5.3 Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment: Revenue Forecast 2020-2030
5.3.1 Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment: Recovery Forecasts (V, U, W, L)
5.3.2 Small Molecule Drugs Segment: Represent the Largest Share of the Overall Market Due to the Rise in the Number of Small Molecule Drugs in Pipeline
6 Global Drug Discovery Outsourcing Market Size Forecast 2020-2030 by Therapeutic Area
6.1 Global Drug Discovery Outsourcing Market by Therapeutic Area Forecast 2020-2030
6.2 Global Drug Discovery Outsourcing Market for Oncology Segment: Revenue Forecast 2020-2030
6.2.1 Global Drug Discovery Outsourcing Market for Oncology Segment: Recovery Forecasts (V, U, W, L)
6.2.2 Oncology Segment: Accounts for the Major Share of the Overall Market Owing to the Rising Focus of Pharmaceutical Companies on the Development of Novel Medicines for the Treatment of Cancer
6.3 Global Drug Discovery Outsourcing Market for Infectious Disease Segment: Revenue Forecast 2020-2030
6.3.1 Global Drug Discovery Outsourcing Market for Infectious Disease Segment: Recovery Forecasts (V, U, W, L)
6.3.2 Infectious Disease Segment: Growth will be Primarily Driven by the Rise in Funds for the Development of Drugs
6.4 Global Drug Discovery Outsourcing Market for Central Nervous System Segment: Revenue Forecast 2020-2030
6.4.1 Global Drug Discovery Outsourcing Market for Central Nervous System Segment: Recovery Forecasts (V, U, W, L)
6.4.2 Central Nervous System Segment: Increased Funding for Research and Early Stage Drug Development for CNS Disorders
6.5 Global Drug Discovery Outsourcing Market Immunology Segment: Revenue Forecast 2020-2030
6.5.1 Global Drug Discovery Outsourcing Market for Immunology Segment: Recovery Forecasts (V, U, W, L)
6.5.2 Immunology Segment: There is Still Significant Growth Potential in the Development of Immunology Drugs
6.6 Global Drug Discovery Outsourcing Market Cardiovascular Disease Segment: Revenue Forecast 2020-2030
6.6.1 Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment: Recovery Forecasts (V, U, W, L)
6.6.2 Cardiovascular Disease Segment: Growing Prevalence of Cardiovascular Diseases is the Key Factor Driving the Demand for the Growth of the Drug Discovery Outsourcing Services
6.7 Global Drug Discovery Outsourcing Market Metabolic Disease Segment: Revenue Forecast 2020-2030
6.7.1 Global Drug Discovery Outsourcing Market for Metabolic Disease Segment: Recovery Forecasts (V, U, W, L)
6.7.2 Metabolic Disease Segment: Fastest Growing Segment of the Market as the Incidence of Metabolic Disorders are Likely to Grow Due to Evolving Lifestyles
6.8 Global Drug Discovery Outsourcing Market Respiratory Disease Segment: Revenue Forecast 2020-2030
6.8.1 Global Drug Discovery Outsourcing Market for Respiratory Disease Segment: Recovery Forecasts (V, U, W, L)
6.8.2 Respiratory Disease Segment: Market will Witnessed Significant Growth Mainly Due to the Rising Incidence of Respiratory Disorders
6.9 Global Drug Discovery Outsourcing Market Others Segment: Revenue Forecast 2020-2030
6.9.1 Global Drug Discovery Outsourcing Market for Others Segment: Recovery Forecasts (V, U, W, L)
7 Regional and Leading National Drug Discovery Outsourcing Market Forecasts 2020-2030
7.1 Global Drug Discovery Outsourcing Market by National Market Forecast 2020-2030
7.1.1 Global Drug Discovery Outsourcing Market Forecast 2020-2030, Recovery Scenarios
7.2 North America - Leads the Global Drug Discovery Outsourcing Market
7.2.1 North America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030
7.2.1.1 North America Drug Discovery Outsourcing Market by Country Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.2.2 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
7.2.2.1 North America Drug Discovery Outsourcing Market Forecast by Service Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.2.3 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
7.2.3.1 North America Drug Discovery Outsourcing Market Forecast by Molecule Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.2.4 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
7.2.4.1 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.2.5 U.S. Drug Discovery Outsourcing Market Forecast 2020-2030
7.2.5.1 U.S. Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.2.5.2 U.S. Drug Discovery Outsourcing Market: Accounts for the One Third of the Global Market Due to the Existence of Well-established CROs
7.2.6 Canada Drug Discovery Outsourcing Market Forecast 2020-2030
7.2.6.1 Canada Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.2.6.2 Canada Drug Discovery Outsourcing Market: Rising Number of Collaborations with Academia, SMEs, and Research Centers is Likely to Contribute to the Market Growth
7.3 Europe - Remains Second Largest Contributor to the Global Market
7.3.1 Europe Drug Discovery Outsourcing Market Forecast by Country, 2020-2030
7.3.1.1 Europe Drug Discovery Outsourcing Market by Country Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.3.2 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
7.3.2.1 Europe Drug Discovery Outsourcing Market Forecast by Service Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.3.3 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
7.3.3.1 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.3.4 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
7.3.4.1 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.3.5 Germany Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.5.1 Germany Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.3.5.2 Germany Drug Discovery Outsourcing Market: High Levels of Government R&D Investments Being Directed into the Country will Boost the Market Growth
7.3.6 France Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.6.1 France Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.3.6.2 France Drug Discovery Outsourcing Market: French Market Dominated by Large Multinationals CROs
7.3.7 UK Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.7.1 UK Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.3.7.2 UK Drug Discovery Outsourcing Market: Largest hub for the CROs
7.3.8 Italy Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.8.1 Italy Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.3.8.2 Italy Drug Discovery Outsourcing Market: Market will Grow Due to Increased Investments in Technology and Innovation of the Entire Supply Chain
7.3.9 Spain Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.9.1 Spain Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.3.9.2 Spain Drug Discovery Outsourcing Market: Robust R&D Infrastructure Coupled with the Launched of Tax Incentives for R&D Spending is Set to Contribute to the Growth of the Market
7.3.10 Russia Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.10.1 Russia Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.3.10.2 Russia Drug Discovery Outsourcing Market: Remains the Fastest Growing Segment Due to Russia’s Ageing Population Coupled with Growing Disease Burden and Increased Government Investments in Healthcare
7.3.11 RoE Drug Discovery Outsourcing Market Forecast 2020-2030
7.3.11.1 RoE Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4 Asia-Pacific - Remains as the Fastest Growing Region in the Global Market
7.4.1 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Country, 2020-2030
7.4.1.1 Asia-Pacific Drug Discovery Outsourcing Market by Country Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.4.2 `Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
7.4.3 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.4.4 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
7.4.4.1 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.4.5 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
7.4.5.1 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.4.6 Japan Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.6.1 Japan Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4.6.2 Japan Drug Discovery Outsourcing Market: Largest Contributor to the Asia-Pacific Market
7.4.7 China Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.7.1 China Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4.7.2 China Drug Discovery Outsourcing Market: Fastest Growing Drug Discovery Outsourcing Market
7.4.8 Australia Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.8.1 Australia Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4.8.2 Australia Drug Discovery Outsourcing Market: Rise in Elderly Population and Related Disease Burden as well as the Growing Adoption of Sedentary Lifestyle
7.4.8 India Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.8.1 India Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4.8.2 India Drug Discovery Outsourcing Market: Major Multinational Companies Investing in India is Set to Drive the Demand for the Drug Discovery Outsourcing Services
7.4.9 South Korea Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.9.1 South Korea Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4.9.2 South Korea Drug Discovery Outsourcing Market: Rise in the Incidence of Chronic Diseases will Drive the Demand for Drug Discovery Services in the Country
7.4.10 Rest of Asia-Pacific Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.10.1 Rest of Asia-Pacific Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.4.11 RoAP Drug Discovery Outsourcing Market Forecast 2020-2030
7.4.11.1 RoAP Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.5 Latin America - Market is Relatively Immature
7.5.1 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030
7.5.1.1 Latin America Drug Discovery Outsourcing Market by Country Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.5.2 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
7.5.2.1 Latin America Drug Discovery Outsourcing Market Forecast by Service Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.5.3 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
7.5.3.1 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.5.4 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
7.5.4.1 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.5.5 Brazil Drug Discovery Outsourcing Market Forecast 2020-2030
7.5.5.1.1 Brazil Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.5.5.1.2 Brazil Drug Discovery Outsourcing Market: Major Contributor to the Latin American Market
7.5.5.2 Mexico Drug Discovery Outsourcing Market Forecast 2020-2030
7.5.5.3 Mexico Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.5.5.4 Mexico Drug Discovery Outsourcing Market: Is One of the Emerging Markets of the Globally
7.5.6 RoLA Drug Discovery Outsourcing Market Forecast 2020-2030
7.5.6.1 RoLA Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.6 Middle East & Africa – Growing Investments of Multinational Companies into the Region
7.6.1 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Country, 2020-2030
7.6.1.1 Middle East & Africa Drug Discovery Outsourcing Market by Country Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.6.2 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
7.6.2.1 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.6.3 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
7.6.3.1 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Molecule Type Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.6.4 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
7.6.4.1 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area Forecast, 2020-2030: Recovery Scenarios (V, U, W, L)
7.6.5 GCC Drug Discovery Outsourcing Market Forecast 2020-2030 - Number of CROs Operating the Region is Expected to Grow
7.6.5.1 GCC Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.6.5.2 GCC Drug Discovery Outsourcing Market: Number of CROs Operating across the Region is Expected to Grow
7.6.6 South Africa Drug Discovery Outsourcing Market Forecast 2020-2030
7.6.6.1 South Africa Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
7.6.6.2 South Africa Drug Discovery Outsourcing Market: African Market Can Expect Strong Growth Due to Significant Demand for Medicines in the Country
7.6.7 RoMEA Drug Discovery Outsourcing Market Forecast 2020-2030
7.6.7.1 RoMEA Drug Discovery Outsourcing Market: Recovery Scenarios (V, U, W, L)
8 Leading Companies in the Drug Discovery Outsourcing Market
8.1 Evotec AG
8.1.1 Evotec AG: Company Snapshot
8.1.2 Evotec AG: Company Overview
8.1.3 Evotec AG Financials, 2015-2019
8.1.4 Evotec AG: Product Portfolio
8.1.5 Evotec AG: Recent Developments
8.2 GVK BIO
8.2.1 GVK BIO: Company Snapshot
8.2.2 GVK BIO: Company Overview
8.2.3 GVK BIO: Product Portfolio
8.2.4 GVK BIO: Recent Developments
8.3 Charles River Laboratories
8.3.1 Charles River Laboratories: Company Snapshot
8.3.2 Charles River Laboratories: Company Overview
8.3.3 Charles River Laboratories Financials, 2015-2019
8.3.4 Charles River Laboratories: Product Portfolio
8.3.5 Charles River Laboratories: Recent Developments
8.4 LabCorp
8.4.1 LabCorp: Company Snapshot
8.4.2 LabCorp: Company Overview
8.4.3 LabCorp: Financials, 2015-2019
8.4.4 LabCorp : Product Portfolio
8.4.5 LabCorp : Recent Developments
8.5 Domainex
8.5.1 Domainex: Company Snapshot
8.5.2 Domainex: Company Overview
8.5.3 Domainex: Product Portfolio
8.5.4 Domainex : Recent Developments
8.6 GenScript Biotech Corporation
8.6.1 GenScript Biotech Corporation: Company Snapshot
8.6.2 GenScript Biotech Corporation: Company Overview
8.6.3 Genscript Biotech Corporation Financials, 2015-2019
8.6.4 GenScript Biotech Corporation: Product Portfolio
8.6.5 GenScript Biotech Corporation: Recent Developments
8.7 Jubilant Biosys Ltd
8.7.1 Jubilant Biosys Ltd: Company Snapshot
8.7.2 Jubilant Biosys Ltd: Company Overview
8.7.3 Jubilant Biosys Ltd Financials, 2015-2019
8.7.4 Jubilant Biosys Ltd: Product Portfolio
8.7.5 Jubilant Biosys Ltd: Recent Developments
8.8 Viva Biotech (Shanghai) Ltd
8.8.1 Viva Biotech (Shanghai) Ltd: Company Snapshot
8.8.2 Viva Biotech (Shanghai) Ltd: Company Overview
8.8.3 Viva Biotech (Shanghai) Ltd: Product Portfolio
8.9 WuXi AppTec
8.9.1 WuXi AppTec: Company Snapshot
8.9.2 WuXi AppTec: Company Overview
8.9.3 WuXi AppTec Financials, 2015-2019
8.9.4 WuXi AppTec: Product Portfolio
8.9.5 WuXi AppTec: Recent Developments
8.10 Dalton Pharma
8.10.1 Dalton Pharma: Company Snapshot
8.10.2 Dalton Pharma: Company Overview
8.10.3 Dalton Pharma: Product Portfolio
8.10.4 Dalton Pharma: Future Outlook
8.10.5 Dalton Pharma y: Recent Developments
8.11 PPD, Inc.
8.11.1 PPD, Inc.: Company Snapshot
8.11.2 PPD, Inc.: Company Overview
8.11.3 PPD, Inc. Financials, 2015-2019
8.11.4 PPD, Inc. : Product Portfolio
8.11.5 PPD, Inc.: Recent Developments
8.12 Pharmaron
8.12.1 Pharmaron: Company Snapshot
8.12.2 Pharmaron: Company Overview
8.12.3 Pharmaron Financials, 2015-2019
8.12.4 Pharmaron: Product Portfolio
8.12.5 Pharmaron: Recent Developments
8.13 Sygnature Discovery
8.13.1 Sygnature Discovery: Company Snapshot
8.13.2 Sygnature Discovery: Company Overview
8.13.3 Sygnature Discovery: Product Portfolio
8.13.4 Sygnature Discovery: Recent Developments
8.14 TCG Lifesciences Pvt. Limited
8.14.1 TCG Lifesciences Pvt. Limited: Company Snapshot
8.14.2 TCG Lifesciences Pvt. Limited: Company Overview
8.14.3 TCG Lifesciences Pvt. Limited: Product Portfolio
8.14.4 TCG Lifesciences Pvt. Limited: Recent Developments
8.15 Selvita
8.15.1 Selvita : Company Snapshot
8.15.2 Selvita : Company Overview
8.15.3 Selvita Financials, 2015-2019
8.15.4 Selvita: Product Portfolio
8.15.5 Selvita: Recent Developments
8.16 Sundia Meditech Co Ltd
8.16.1 Sundia Meditech Co Ltd : Company Snapshot
8.16.2 Sundia Meditech Co Ltd : Company Overview
8.16.3 Sundia Meditech Co Ltd : Product Portfolio
8.17 Eurofins
8.17.1 Eurofins: Company Snapshot
8.17.2 Eurofins: Company Overview
8.17.3 Eurofins Financials, 2015-2019
8.17.4 Eurofins: Product Portfolio
8.17.5 Eurofins: Future Outlook
8.17.6 Eurofins: Recent Developments
8.18 Thermo Fisher Scientific Inc.
8.18.1 Thermo Fisher Scientific Inc.: Company Snapshot
8.18.2 Thermo Fisher Scientific Inc.: Company Overview
8.18.3 Thermo Fisher Scientific Inc. Financials, 2015-2019
8.18.4 Thermo Fisher Scientific Inc.: Product Portfolio
8.18.5 Thermo Fisher Scientific Inc.: Recent Developments
8.19 Syngene
8.19.1 Syngene : Company Snapshot
8.19.2 Syngene: Company Overview
8.19.3 Syngene Financials, 2015-2019
8.19.4 Syngene : Product Portfolio
8.19.5 Syngene : Recent Developments
8.20 QIAGEN N.V.
8.20.1 QIAGEN N.V. : Company Snapshot
8.20.2 QIAGEN N.V. : Company Overview
8.20.3 QIAGEN N.V. Financials, 2015-2019
8.20.4 QIAGEN N.V. : Product Portfolio
8.20.5 QIAGEN N.V. : Recent Developments
9 Conclusions and Recommendations
9.1 Market Overview
9.2 Lead Optimization will be the Fastest Growing Sector
9.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
9.4 Continued Growth in Alliances and Collaborations
9.5 Future Prospects
9.6 Concluding Remarks
10 Glossary
List of Tables
Table 1 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 2 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 3 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 4 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 5 Global Drug Discovery Outsourcing Market, 2020-2030 (US$ million, CAGR %)
Table 6 Selected Drug Discovery Outsourcing Alliances, 2017-2020
Table 7 Global Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %, CAGR %)
Table 8 Global Drug Discovery Outsourcing Market for Chemistry Services Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 9 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 10 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 11 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 12 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 13 Global Drug Discovery Outsourcing Market for Biology Services Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 14 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 15 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 16 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 17 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 18 Global Drug Discovery Outsourcing Market for Lead Optimization Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 19 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 20 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 21 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 22 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 23 Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 24 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 25 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 26 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 27 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 28 Global Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %, CAGR %)
Table 29 Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 30 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 31 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 32 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 33 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 34 Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 35 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 36 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 37 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 38 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 39 Global Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %, CAGR %)
Table 40 Global Drug Discovery Outsourcing Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 41 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 42 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 43 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 44 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 45 Global Drug Discovery Outsourcing Market for Infectious Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 46 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 47 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 48 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 49 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 50 Global Drug Discovery Outsourcing Market for Central Nervous System Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 51 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 52 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 53 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 54 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 55 Global Drug Discovery Outsourcing Market for Immunology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 56 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 57 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 58 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 59 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 60 Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 61 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 62 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 63 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 64 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 65 Global Drug Discovery Outsourcing Market for Metabolic Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 66 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 67 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 68 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 69 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 70 Global Drug Discovery Outsourcing Market for Respiratory Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 71 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 72 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 73 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 74 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 75 Global Drug Discovery Outsourcing Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 76 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 77 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 78 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 79 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
Table 80 Global Drug Discovery Outsourcing Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 81 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 82 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 83 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 84 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market Forecast by Region, 2020-2030 (US$ million, AGR %)
Table 85 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 86 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 87 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 88 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 89 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 90 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 91 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 92 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 93 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 94 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 95 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area Type, 2020-2030 (US$ million, AGR %)
Table 96 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 97 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 98 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 99 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 100 U.S. Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 101 U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 102 U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 103 U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 104 U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 105 Canada Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 106 Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 107 Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 108 Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 109 Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 110 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 111 “V” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 112 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 113 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 114 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 115 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 116 “V” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 117 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 118 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 119 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 120 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area Type, 2020-2030 (US$ million, AGR %)
Table 121 “V” Shaped Recovery: Europe America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 122 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 123 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 124 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 125 Germany Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 126 Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 127 Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 128 Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 129 Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 130 France Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 131 France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 132 France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 133 France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 134 France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 135 UK Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 136 UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 137 UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 138 UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 139 UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 140 Italy Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 141 Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 142 Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 143 Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 144 Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 145 Spain Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 146 Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 147 Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 148 Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 149 Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 150 Russia Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 151 Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 152 Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 153 Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 154 Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 155 RoE Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 156 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 157 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 158 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 159 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 160 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 161 “V” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 162 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 163 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 164 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 165 Asia-Pacific Drug Discovery Outsourcing Market Forecast By Molecule Type, 2020-2030 (US$ million, AGR %)
Table 166 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 167 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 168 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 169 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 170 Asia-Pacific Drug Discovery Outsourcing Market Forecast By Therapeutic Area Type, 2020-2030 (US$ million, AGR %)
Table 171 “V” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 172 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 173 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 174 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 175 Japan Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 176 Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 177 Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 178 Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 179 Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 180 China Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 181 China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 182 China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 183 China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 184 China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 185 Australia Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 186 Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 187 Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 188 Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 189 Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 190 India Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 191 India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 192 India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 193 India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 194 India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 195 South Korea Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 196 South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 197 South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 198 South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 199 South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 200 Rest of Asia-Pacific Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 201 Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 202 Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 203 Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 204 Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 205 RoAP Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 206 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 207 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 208 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 209 RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 210 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 211 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 212 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 213 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 214 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 215 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 216 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 217 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 218 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 219 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 220 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area Type, 2020-2030 (US$ million, AGR %)
Table 221 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 222 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 223 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 224 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 225 Brazil Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 226 Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 227 Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 228 Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 229 Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 230 Mexico Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 231 Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 232 Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 233 Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 234 Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 235 Mexico Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 236 RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 237 RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 238 RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 239 RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 240 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 241 “V” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 242 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 243 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 244 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Table 245 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 246 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 247 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 248 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 249 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Table 250 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area Type, 2020-2030 (US$ million, AGR %)
Table 251 “V” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 252 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 253 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 254 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Table 255 GCC Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 256 GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 257 GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 258 GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 259 GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 260 South Africa Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 261 South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 262 South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 263 South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 264 South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 265 RoMEA Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
Table 266 RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): V-Shaped Recovery
Table 267 RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): U-Shaped Recovery
Table 268 RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): W-Shaped Recovery
Table 269 RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%): L-Shaped Recovery
Table 270 Evotec AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Evotec AG Product Portfolio
Table 272 Evotec AG: Recent Developments
Table 273 GVK BIO Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 GVK BIO Product Portfolio
Table 275 GVK BIO: Recent Developments
Table 276 Charles River Laboratories Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 Charles River Laboratories Product Portfolio
Table 278 Charles River Laboratories : Recent Developments
Table 279 LabCorp Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 LabCorp Product Portfolio
Table 281 LabCorp: Recent Developments
Table 282 Domainex Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 283 Domainex Product Portfolio
Table 284 Domainex: Recent Developments
Table 285 GenScript Biotech Corporation Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 286 GenScript Biotech Corporation Product Portfolio
Table 287 GenScript Biotech Corporation and: Recent Developments
Table 288 Jubilant Biosys Ltd Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Jubilant Biosys Ltd Product Portfolio
Table 290 Jubilant Biosys Ltd: Recent Developments
Table 291 Viva Biotech (Shanghai) Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Viva Biotech (Shanghai) Ltd Product Portfolio
Table 293 WuXi AppTec Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 294 WuXi AppTec Product Portfolio
Table 295 WuXi AppTec: Recent Developments
Table 296 Dalton Pharma Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 297 Dalton Pharma Product Portfolio
Table 298 Dalton Pharma: Recent Developments
Table 299 PPD, Inc. Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 300 PPD, Inc. Product Portfolio
Table 301 PPD, Inc. Company: Recent Developments
Table 302 Pharmaron Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 Pharmaron Company Product Portfolio
Table 304 Pharmaron Company: Recent Developments
Table 305 Sygnature Discovery Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 306 Sygnature Discovery Product Portfolio
Table 307 Sygnature Discovery: Recent Developments
Table 308 Becton, Dickinson and Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 309 TCG Lifesciences Pvt. Limited Product Portfolio
Table 310 TCG Lifesciences Pvt. Limited: Recent Developments
Table 311 Selvita Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 312 Selvita Product Portfolio
Table 313 Selvita: Recent Developments
Table 314 Sundia Meditech Co Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Sundia Meditech Co Ltd Product Portfolio
Table 316 Eurofins Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 317 Eurofins Product Portfolio
Table 318 Eurofins Company: Recent Developments
Table 319 Thermo Fisher Scientific Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 320 Thermo Fisher Scientific Inc. Product Portfolio
Table 321 Thermo Fisher Scientific Inc.: Recent Developments
Table 322 Syngene Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 323 Syngene Product Portfolio
Table 324 Syngene Company: Recent Developments
Table 325 QIAGEN N.V. Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 326 QIAGEN N.V. Product Portfolio
Table 327 QIAGEN N.V. : Recent Developments
List of Figures
Figure 1 Global Drug Discovery Outsourcing Market Segmentation
Figure 2 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 3 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 4 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 5 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 6 Global Drug Discovery Outsourcing Market Research Methodology: Data Triangulation
Figure 7 Global Drug Discovery Outsourcing Market Overview
Figure 8 Porter’s Five Forces Analysis
Figure 9 SWOT Analysis
Figure 10 Global Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR %)
Figure 11 Global Drug Discovery Outsourcing Market Share Forecast by Service Type, 2020, 2025, 2030 (%)
Figure 12 Global Drug Discovery Outsourcing Market for Chemistry Services Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 13 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 14 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 15 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 16 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Chemistry Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 17 Global Drug Discovery Outsourcing Market for Biology Services Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 18 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 19 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 20 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 21 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Biology Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 22 Global Drug Discovery Outsourcing Market for Lead Optimization Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 23 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 24 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 25 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 26 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Optimization Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 27 Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 28 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 29 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 30 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 31 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Lead Identification & Screening Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 32 Global Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR %)
Figure 33 Global Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2020, 2025, 2030 (%)
Figure 34 Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 35 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 36 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 37 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 38 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Large Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 39 Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 40 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 41 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 42 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 43 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Small Molecule Drugs Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 44 Global Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
Figure 45 Global Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2020, 2025, 2030 (%)
Figure 46 Global Drug Discovery Outsourcing Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 47 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 48 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 49 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 50 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 51 Global Drug Discovery Outsourcing Market for Infectious Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 52 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 53 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 54 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 55 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Infectious Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 56 Global Drug Discovery Outsourcing Market for Central Nervous System Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 57 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 58 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 59 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 60 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Central Nervous System Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 61 Global Drug Discovery Outsourcing Market for Immunology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 62 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 63 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 64 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 65 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 66 Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 67 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 68 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 69 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 70 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Cardiovascular Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 71 Global Drug Discovery Outsourcing Market for Metabolic Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 72 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 73 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 74 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 75 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Metabolic Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 76 Global Drug Discovery Outsourcing Market for Respiratory Disease Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 77 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 78 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 79 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 80 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Respiratory Disease Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 81 Global Drug Discovery Outsourcing Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 82 “V” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 83 “U” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 84 “W” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 85 “L” Shaped Recovery: Global Drug Discovery Outsourcing Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 86 Global Drug Discovery Outsourcing Market Forecast by Region 2020-2030 (US$ million)
Figure 87 North America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million)
Figure 88 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 89 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 90 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 91 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 92 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 93 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 94 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 95 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 96 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 97 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 98 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 99 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 100 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 101 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 102 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 103 “V” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 104 “U” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 105 “W” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 106 “L” Shaped Recovery: North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 107 U.S. Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 108 “V”-Shaped Recovery: U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 109 “U”-Shaped Recovery: U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 110 “W”-Shaped Recovery: U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 111 “L”-Shaped Recovery: U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 112 Canada Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 113 “V”-Shaped Recovery: Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 114 “U”-Shaped Recovery: Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 115 “W”-Shaped Recovery: Canada Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 116 “L”-Shaped Recovery: U.S. Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 117 Europe Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million)
Figure 118 “V” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 119 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 120 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 121 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 122 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 123 “V” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 124 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 125 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 126 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 127 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 128 “V” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 129 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 130 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 131 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 132 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 133 “V” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 134 “U” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 135 “W” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 136 “L” Shaped Recovery: Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 137 Germany Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 138 “V”-Shaped Recovery: Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 139 “U”-Shaped Recovery: Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 140 “W”-Shaped Recovery: Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 141 “L”-Shaped Recovery: Germany Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 142 France Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 143 “V”-Shaped Recovery: France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 144 “U”-Shaped Recovery: France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 145 “W”-Shaped Recovery: France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 146 “L”-Shaped Recovery: France Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 147 UK Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 148 “V”-Shaped Recovery: UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 149 “U”-Shaped Recovery: UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 150 “W”-Shaped Recovery: UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 151 “L”-Shaped Recovery: UK Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 152 Italy Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 153 “V”-Shaped Recovery: Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 154 “U”-Shaped Recovery: Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 155 “W”-Shaped Recovery: Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 156 “L”-Shaped Recovery: Italy Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 157 Spain Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 158 “V”-Shaped Recovery: Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 159 “U”-Shaped Recovery: Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 160 “W”-Shaped Recovery: Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 161 “L”-Shaped Recovery: Spain Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 162 Russia Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 163 “V”-Shaped Recovery: Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 164 “U”-Shaped Recovery: Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 165 “W”-Shaped Recovery: Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 166 “L”-Shaped Recovery: Russia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 167 RoE Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 168 “V”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 169 “U”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 170 “W”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 171 “L”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 172 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million)
Figure 173 Asia-Pacific Drug Discovery Outsourcing Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 174 “V” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 175 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 176 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 177 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 178 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 179 “V” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 180 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 181 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 182 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 183 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 184 “V” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 185 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 186 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 187 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 188 Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 189 “V” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 190 “U” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 191 “W” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 192 “L” Shaped Recovery: Asia-Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 193 Japan Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 194 “V”-Shaped Recovery: Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 195 “U”-Shaped Recovery: Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 196 “W”-Shaped Recovery: Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 197 “L”-Shaped Recovery: Japan Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 198 China Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 199 “V”-Shaped Recovery: China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 200 “U”-Shaped Recovery: China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 201 “W”-Shaped Recovery: China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 202 “L”-Shaped Recovery: China Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 203 Australia Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 204 “V”-Shaped Recovery: Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 205 “U”-Shaped Recovery: Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 206 “W”-Shaped Recovery: Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 207 “L”-Shaped Recovery: Australia Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 208 India Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 209 “V”-Shaped Recovery: India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 210 “U”-Shaped Recovery: India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 211 “W”-Shaped Recovery: India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 212 “L”-Shaped Recovery: India Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 213 South Korea Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 214 “V”-Shaped Recovery: South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 215 “U”-Shaped Recovery: South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 216 “W”-Shaped Recovery: South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 217 “L”-Shaped Recovery: South Korea Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 218 Rest of Asia-Pacific Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 219 “V”-Shaped Recovery: Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 220 “U”-Shaped Recovery: Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 221 “W”-Shaped Recovery: Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 222 “L”-Shaped Recovery: Rest of Asia-Pacific Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 223 RoE Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 224 “V”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 225 “U”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 226 “W”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 227 “L”-Shaped Recovery: RoE Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 228 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million)
Figure 229 Latin America Drug Discovery Outsourcing Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 230 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 231 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 232 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 233 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 234 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 235 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 236 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 237 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 238 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 239 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 240 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 241 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 242 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 243 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 244 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 245 “V” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 246 “U” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 247 “W” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 248 “L” Shaped Recovery: Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 249 Brazil Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 250 “V”-Shaped Recovery: Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 251 “U”-Shaped Recovery: Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 252 “W”-Shaped Recovery: Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 253 “L”-Shaped Recovery: Brazil Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 254 Mexico Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 255 “V”-Shaped Recovery: Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 256 “U”-Shaped Recovery: Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 257 “W”-Shaped Recovery: Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 258 “L”-Shaped Recovery: Mexico Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 259 RoLA Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 260 “V”-Shaped Recovery: RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 261 “U”-Shaped Recovery: RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 262 “W”-Shaped Recovery: RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 263 “L”-Shaped Recovery: RoLA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 264 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million)
Figure 265 Middle East & Africa Drug Discovery Outsourcing Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 266 “V” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 267 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 268 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 269 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast by Country, 2020-2030 (US$ million, AGR%)
Figure 270 Middle East & Africa Drug Discovery Outsourcing Market Forecast by Service Type, 2020-2030 (US$ million, AGR%)
Figure 271 “V” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Service Type, 2020-2030 (US$ million, AGR%)
Figure 272 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Service Type, 2020-2030 (US$ million, AGR%)
Figure 273 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Service Type, 2020-2030 (US$ million, AGR%)
Figure 274 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Service Type, 2020-2030 (US$ million, AGR%)
Figure 275 Middle East & Africa Drug Discovery Outsourcing Market Forecast By Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 276 “V” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 277 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 278 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 279 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Molecule Type, 2020-2030 (US$ million, AGR%)
Figure 280 Middle East & Africa Drug Discovery Outsourcing Market Forecast By Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 281 “V” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 282 “U” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 283 “W” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 284 “L” Shaped Recovery: Middle East & Africa Drug Discovery Outsourcing Market Forecast By Therapeutic Area, 2020-2030 (US$ million, AGR%)
Figure 285 GCC Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 286 “V”-Shaped Recovery: GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 287 “U”-Shaped Recovery: GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 288 “W”-Shaped Recovery: GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 289 “L”-Shaped Recovery: GCC Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 290 South Africa Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 291 “V”-Shaped Recovery: South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 292 “U”-Shaped Recovery: South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 293 “W”-Shaped Recovery: South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 294 “L”-Shaped Recovery: South Africa Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 295 RoMEA Drug Discovery Outsourcing Market Forecast 2020-2030 (US$ million, AGR %)
Figure 296 “V”-Shaped Recovery: RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 297 “U”-Shaped Recovery: RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 298 “W”-Shaped Recovery: RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 299 “L”-Shaped Recovery: RoMEA Drug Discovery Outsourcing Market, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 300 Drug Discovery Outsourcing Market: Company Share Analysis (%), 2019
Figure 301 Evotec AG: Financials, 2015-2019 (US$ million, AGR %)
Figure 302 Charles River Laboratories: Financials, 2015-2019 (US$ million, AGR %)
Figure 303 LabCorp Financials, 2015-2019 (US$ million, AGR %)
Figure 304 Genscript Biotech Corporation Financials, 2015-2019 (US$ million, AGR %)
Figure 305 Jubilant Biosys Ltd Financials, 2015-2019 (US$ million, AGR %)
Figure 306 WuXi AppTec Financials, 2015-2019 (RMB million, AGR %)
Figure 307 PPD, Inc. Financials, 2015-2019 (US$ million, AGR %)
Figure 308 Pharmaron Financials, 2015-2019 (US$ million, AGR %)
Figure 309 Selvita Financials, 2015-2019 (PLN million, AGR %)
Figure 310 Eurofins Financials, 2015-2019 ($ million, AGR %)
Figure 311 Thermo Fisher Scientific Inc. Financials, 2015-2019 (US$ million, AGR %)
Figure 312 Syngene Financials, 2015-2019 (US$ million, AGR %)
Figure 313 QIAGEN N.V. Financials, 2015-2019 (US$ million, AGR %)
Companies Profiled in the Report:
Charles River Laboratories
Dalton Pharma
Domainex
Eurofins
Evotec AG
Genscript Biotech Corporation
GVK BIO
Jubilant Biosys Ltd
LabCorp
Pharmaron
PPD
QIAGEN N.V.
Selvita
Sundia Meditech Co Ltd
Sygnature Discovery
Syngene
TCG Lifesciences Pvt. Limited
Thermo Fisher Scientific Inc.
Viva Biotech (Shanghai) Ltd
WuXi AppTec
List of Companies Mentioned in the Report:
Aeovian Pharmaceuticals, Inc.
Almirall, S.A.
Amgen Inc.
ApconiX
Aptuit
Aragen Bioscience, Inc.
AstraZeneca
Averica Discovery Services Inc.
Bayer AG
BioFocus
BioNTech
Bristol-Myers Squibb
Celgene
CENTOGENE AG
Citoxlab
Deciphex
Dotmatics
Eisai
Eli Lilly
Exscientia
Gilead
Harbour BioMed (HBM)
HD Biosciences (HDB)
Johnson & Johnson
Just Biotherapeutics
KWS BioTest
Nimbus Therapeutics
Novartis
Novo Nordisk
Pathios Therapeutics
Pelago Bioscience
Pfizer
PharmaResources
PhoreMost Ltd
PhysioStim
QUANTRO Therapeutics GmbH
Sanofi
Sciformix Corporation
SilcsBio
Takeda Pharmaceutical Company Limited (Takeda)
UCB
List of Organizations Mentioned in the Report:
Academy of Managed Care Pharmacists
Accessible Medicines Association
America's Health Insurance Plans
American Pharmaceutical Research and Manufacturers
Blue Cross Blue Shield Association and the National Association of Chain Drug Stores
Blueprint Neurotherapeutics Network (BPN)
Central and Eastern European (CEE)
European Molecular Biology Laboratory
Food and Drug Administration (FDA)
Helmholtz Center for Infection Research (HZI)
Mark Cancer Research Foundation
National Institutes of Health (NIH)
National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN)
National Specialty Pharmacy Association
Pharmaceutical Care Management Association
ResearchPoint Global (RPG)
University of California, San Francisco (UCSF)
World Health Organisation (WHO)
Download sample pages
Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Report 2020-2030Related reports
Next Generation Sequencing Market Report 2021-2031
Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical...Full DetailsPublished: 01 June 2021Biopharmaceuticals Contract Manufacturing Market Report 2020-2030
As of 2019, the global biopharmaceuticals market’s size was estimated at ~$232 billion. It is expected to grow at a...
Full DetailsPublished: 04 March 2020OTC Drugs & Dietary Supplements Market Report 2021-2031
From a long-term perspective, the rapid growth of the mid-class economy will enhance the demand for OTC products in emerging...Full DetailsPublished: 05 August 2021Global Genomics Market Report 2018-2028
The global genomics market is estimated to reach $23bn by 2022. In 2017, the diagnostic test segment held 27% of...Full DetailsPublished: 31 October 2018Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2020-2030
Overall world revenue for Cancer Immunotherapy Drug Discovery Outsourcing will surpass $750 million in 2020, our work calculates. We predict...
Full DetailsPublished: 01 January 1970Gene Therapy R&D and Revenue Forecasts 2020-2030
The gene therapy market is projected to grow at a CAGR of 32% in the first half of the forecast...
Full DetailsPublished: 06 March 2020Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030
Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020.
...Full DetailsPublished: 12 February 2020Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power,...Full DetailsPublished: 31 March 2021Precision Medicine Market Report 2020-2030
Our 193 pages report provides 107 tables, 107 charts, and graphs. Read on to discover the most lucrative areas in...
Full DetailsPublished: 27 May 2020NGS-Based RNA Sequencing Market Report 2021-2031
The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic...Full DetailsPublished: 05 May 2021
Download sample pages
Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Report 2020-2030Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
